Wearable ECGs and EKGs monitors bring digital technology and healthcare together and can greatly improve the lives of people who have heart diseases such as tachycardia, premature heartbeats, arrhythmia, and psychological pressure. With these advancements, it’s like your doctor is with you all the time to monitor and record your health.
Many pregnant women sleep on their backs during the late stages of pregnancy. This, a new study found, can increase the risk of stillbirths due to oxygen deprivation followed by improper breathing of the fetus. Though positional therapy is suggested by the physicians, there was no concrete prove up until now.
A survey spanning 3 years by Rock Health on 4000 U.S residents, to assess their usage and opinions on digital health, revealed that 87% of Americans were using a minimum of one digital health service in 2017 as compared to 80% in 2015.
Wearable Medical devices took the world by storm and have altered our way of life forever. In 2016 the market for wearables reached an estimated $2 billion and experts predict that this number will skyrocket to $6 billion by 2023.
Mike Bolduc, global marketing manager at C&K, once stated that since the market growth in terms of wearable medical devices wholesale reached $4 billion in 2017, it is expected to increase by 35 percent by 2019.
A new member has been added to the Fitbit Charge Family namely the Fitbit Charge 3 with an additional feature of measuring the SpO2. The new version will hit the market in October.
Fitbit has generated yet another mHealth partnership in its bidding to make the fitness wearables a major component in connected health programs.
The research team from Stanford University have invented a novel wearable that could measure the level of a patient’s cortisol from their sweat. Cortisol is a hormone linked to stress, which takes several days to test. This scientific discovery was recently published in Science Advances.
Johnson & Johnson is moving out from the diabetes business and sold its Calibra product (marketed as OneTouch Via, but never launched) to a 10-year-old company named CeQur, which was already working on a similar insulin-delivery wearable. The terms and conditions of this deal have not yet been yet disclosed, but CeQur has attained an exclusive worldwide license for this technology.
A study report published in Nature's Digital Medicine partner journal shows that the wearable monitor Fitbit Charge HR could assess the health condition of cancer patients and predict their adverse events.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.